Author | Hans Hammers, MD, PhD | OncLive

Author | Hans Hammers, MD, PhD

Articles

Dr. Hammers on Challenges With CAR T-Cell Therapy in RCC

September 16, 2019

Video

Hans Hammers, MD, PhD, associate professor of internal medicine, Division of Hematology-Oncology, UT Southwestern Medical Center, discusses the challenges with using CAR T-cell therapy in renal cell carcinoma.

Dr. Hammers on the Future of Immunotherapy in RCC

February 07, 2018

Video

Hans Hammers, MD, PhD, associate professor, Internal Medicine, UT Southwestern Medical Center, discusses the future of immunotherapy for patients with renal cell carcinoma (RCC).

Dr. Hammers on the Long-Term Benefits of the CheckMate-214 Study in RCC

January 11, 2018

Video

Hans Hammers, MD, PhD, associate professor, Internal Medicine, UT Southwestern Medical Center, discusses the long-term benefits of the CheckMate-214 study in patients with renal cell carcinoma (RCC).

Dr. Hammers on the CheckMate-214 Study for RCC

December 06, 2017

Video

Hans Hammers, MD, PhD, associate professor, Internal Medicine, UT Southwestern Medical Center, discusses the CheckMate-214 study for patients with renal cell carcinoma (RCC).

x